ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $691,000 | -9.9% | 36,748 | 0.0% | 0.36% | -7.8% |
| Q3 2016 | $767,000 | +30.4% | 36,748 | +59.4% | 0.39% | +11.5% |
| Q2 2016 | $588,000 | -3.6% | 23,048 | 0.0% | 0.35% | +7.1% |
| Q1 2016 | $610,000 | -53.1% | 23,048 | -24.1% | 0.32% | -51.0% |
| Q4 2015 | $1,300,000 | +123.0% | 30,384 | +38.1% | 0.66% | +104.0% |
| Q3 2015 | $583,000 | -20.5% | 22,000 | 0.0% | 0.32% | -21.4% |
| Q2 2015 | $733,000 | – | 22,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |